Skip to content


Improve investments decisions in pharma with daily intelligence on financials trends, clinical trials, patents, competitors, publication statistics and reimbursement codes.


Pharma Market Predictive Modeling

The Following Datasets are Not Part of a Subscription and Only Available with Special Access
Request Access

Disease Frequencies

Number of disease indications reported in the US
This dataset is used to quantitate disease burdens and potential market sizes of a drug.

Clinical Trial Success Rates

Probability of drugs, according to disease indication, moving through clinical trial stages
This dataset is used to predict the success rate of a company based on historical trends of developing a drug for a disease indication. 

Curated Financial Data

Company revenues per drug
This dataset contains highly curated company revenues per drug and is used to predict future financial performances. 

Standardized Company Names

Canonical names for all drug companies
This dataset is used to map all versions of a company name in order to better aggregate features such as revenues, drugs, stock pricing.

Custom Datasets

Expert Collaboration
Talk to us about building a customized dataset.

Talk to Us

Case Studies


Financial Analysis of Competitive Drugs

A case study using PharmaKB to compare competing commercial drugs. Financial investors and pharmaceutical industry leaders utilize the information in PharmaKB to make superior investment and product development decisions...

Read More




Method for Trend Based Forecasting of Drug Revenues

A case study using PharmaKB to predict company revenues from key indicators of research and market performance…

Read More




Patent Cliff Analysis Support for Generic Drug Decisions

Patent termination events have a startling effect on company revenue. This case study shows FDA reported patent terminations for Rheumatoid Arthritis drugs and summarizes the timing of opportunities for generics companies to enter the market.…

Read More




Tracking Trends and Revenue (Cancer Drugs)

A case study using PharmaKB data to explore trending cancer therapies for multiple myeloma and their impact on revenues of existing treatment regimens. Overall, this case study demonstrates how PharmaKB can be used to investigate changes to the treatment landscape for a particular disease…

Read More